Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
Myoken
Yoshinari
Y
Department of Oral Surgery, Hiroshima Red Cross Atomic Bomb Survivors Hospital, Hiroshima, Japan. myoken@do5.enjoy.ne.jp
Kyo
Tai-Ichi
T
Kohara
Tadahiro
T
Fujihara
Megumu
M
Sugata
Tatsumi
T
Mikami
Yuzuru
Y
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002176:Candida albicans / Q000187:drug effects; D002177:Candidiasis / Q000188:drug therapy*; D018890:Chemoprevention; D004352:Drug Resistance, Microbial; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D016469:Fungemia / Q000188:drug therapy*; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009503:Neutropenia / Q000209:etiology
D000935:Antifungal Agents; D000970:Antineoplastic Agents; D000666:Amphotericin B; D015725:Fluconazole